Latisse: Long lashes, longer list of risks

Recently, we reported on some safety concerns surrounding the use of the eyelash-enhancing drug Latisse, including some common side effects, such as red and itchy eyes, and what the ad for this controversial drug calls a potential for "eyelid skin darkening," and "increased brown iris pigmentation."

Our new video takes a closer look at the health drawbacks and the advertisement behind this drug, featuring celebrity spokesperson Brooke Shields. Take a look as ShopSmart magazine editor, Lisa Freeman, and our medical consultant, Dr. Amy Newberger, tell you why the risks of using Latisse may outweigh the drug's cosmetic benefits.

—Ginger Skinner

For more on Latisse, read our previous blog, and find out what our sister-blog Consumerist has to say about the drug's side effects.

Comments

[elizabeth]

Has there been any reports of increase brown iris pigmentation in anyone who has used Latisse?

[Shaune]

I think that the risks for Latisse can be overplayed. Lumigan has been used for years in much higher doses with few side effects bar those listed with Latisse. During the trial study for Latisse there were no reports of iris discoloration. However, because we love to sue each other, it was wise of them to list this as a potential side effect because it is known to happen when used directly in the eye for glaucoma.

[Jim]

The FDA shouldn't have allowed this. All they're doing is scrubbing the competition of generics from entering the market. I imagine the Lumigan patent is almost up, so they had to find an "alternative" use for it.